| Overview |
| bsm-90184r-50µL |
| Ubiquitin specific peptidase 13 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human USP13 |
| 750-800/863 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 8975 |
| Q92995 |
| USP13; Ubiquitin Specific Peptidase 13; Ubiquitin Specific Protease 13 (Isopeptidase T-3); Ubiquitin-Specific-Processing Protease 13; Ubiquitin Carboxyl-Terminal Hydrolase 13; Deubiquitinating Enzyme 13; Ubiquitin Thioesterase 13; Isopeptidase T-3; IsoT-3; ISOT-3; ISOT3; Ubiquitin Specific Peptidase 13 (Isopeptidase T-3); Ubiquitin Thiolesterase 13; EC 3.4.19.12; EC 3.1.2.15 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |